{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T20:35:32Z","timestamp":1773779732186,"version":"3.50.1"},"reference-count":25,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child Educ Pract Ed"],"accepted":{"date-parts":[[2019,4,22]]},"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:p>There are inconsistencies in how newborns are managed following exposure to varicella, ranging from reassurance and observation to administration of varicella zoster immunoglobulin (VZIG) and admission to hospital for varying length courses of intravenous aciclovir.<\/jats:p>\n               <jats:p>Hospitalised preterm babies exposed to varicella should receive VZIG. Administration can otherwise be limited to pregnant non-immune women or to newborns if there is development of maternal chickenpox from 5 days prior to delivery up to 48\u2009hours postdelivery. Intravenous aciclovir is only recommended in cases of newborn disease despite VZIG or in severe disease. The use of VZIG may not prevent varicella but may reduce severity of disease.<\/jats:p>\n               <jats:p>In this article, we review the evidence for risk to non-immune mothers, the fetus and newborns who had different types of exposure to varicella, with recommendations for management and treatment of confirmed neonatal chickenpox.<\/jats:p>","DOI":"10.1136\/archdischild-2018-316715","type":"journal-article","created":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T17:19:32Z","timestamp":1558631972000},"page":"24-30","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Fifteen-minute consultation: Prevention and treatment of chickenpox in newborns"],"prefix":"10.1136","volume":"105","author":[{"given":"Charlotte","family":"Holland","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Oxford Radcliffe Hospitals NHS Trust, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish","family":"Sadarangani","sequence":"additional","affiliation":[{"name":"Vaccine Evaluation Center, BC Children\u2019s Hospital Research Institute, Vancouver, British Columbia, Canada"},{"name":"Department of Pediatrics, The University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,5,23]]},"reference":[{"key":"2025090700454702000_105.1.24.1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jp.7210599"},{"key":"2025090700454702000_105.1.24.2","unstructured":"England PH . Varicella: the green book, chapter 34. Immunisation against infectious disease: London, UK, 2015."},{"key":"2025090700454702000_105.1.24.3","unstructured":"Paediatric Formulary Committee. British national formulary for children. London: BMJ Group, Pharmaceutical Press and RCPCH Publications, 2016."},{"key":"2025090700454702000_105.1.24.4","doi-asserted-by":"publisher","DOI":"10.1007\/s00430-006-0032-z"},{"key":"2025090700454702000_105.1.24.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(98)80156-4"},{"key":"2025090700454702000_105.1.24.6","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199012000-00001"},{"key":"2025090700454702000_105.1.24.7","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3109\/01443615.2015.1127905","article-title":"Congenital varicella syndrome: A systematic review","volume":"36","author":"Ahn","year":"2016","journal-title":"J Obstet Gynaecol"},{"key":"2025090700454702000_105.1.24.8","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1093\/infdis\/166.Supplement_1.S42","article-title":"Varicella in pregnancy, the fetus, and the newborn: problems in management","volume":"166 Suppl 1","author":"Brunell","year":"1992","journal-title":"J Infect Dis"},{"key":"2025090700454702000_105.1.24.9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s13312-014-0320-4","article-title":"Hemorrhagic varicella in a newborn","volume":"51","author":"Aparajitha","year":"2014","journal-title":"Indian Pediatr"},{"key":"2025090700454702000_105.1.24.10","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-198509000-00013"},{"key":"2025090700454702000_105.1.24.11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00006454-198601000-00018","article-title":"Disseminated varicella in a neonate: implications for immunoprophylaxis of neonates postnatally exposed to varicella","volume":"5","author":"Rubin","year":"1986","journal-title":"Pediatr Infect Dis"},{"key":"2025090700454702000_105.1.24.12","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31825d2a1b"},{"key":"2025090700454702000_105.1.24.13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1046\/j.1440-1754.2000.00460.x","article-title":"Neonatal chickenpox","volume":"36","author":"Isaacs","year":"2000","journal-title":"J Paediatr Child Health"},{"key":"2025090700454702000_105.1.24.14","doi-asserted-by":"publisher","DOI":"10.4161\/hv.7.5.14820"},{"key":"2025090700454702000_105.1.24.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(82)80505-2"},{"key":"2025090700454702000_105.1.24.16","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/x004310100839","article-title":"Varicella zoster infection and IgG antibody formation in a 10-week-old preterm infant despite maternal immunity","volume":"160","author":"Koehring","year":"2001","journal-title":"Eur J Pediatr"},{"key":"2025090700454702000_105.1.24.17","unstructured":"Public Health England. Updated restrictions on use of varicella zoster immunoglobulin (VZIG) during supply shortage: advice for health professionals. 2018."},{"key":"2025090700454702000_105.1.24.18","first-page":"30","article-title":"Prevention of varicella. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Centers for Disease Control and Prevention","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025090700454702000_105.1.24.19","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2011-0017"},{"key":"2025090700454702000_105.1.24.20","doi-asserted-by":"publisher","DOI":"10.1136\/adc.88.10.862"},{"key":"2025090700454702000_105.1.24.21","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2015-308730"},{"key":"2025090700454702000_105.1.24.22","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2010.206037"},{"key":"2025090700454702000_105.1.24.23","doi-asserted-by":"publisher","DOI":"10.1086\/522156"},{"key":"2025090700454702000_105.1.24.24","doi-asserted-by":"crossref","first-page":"902","DOI":"10.15585\/mmwr.mm6534a4","article-title":"Epidemiology of Varicella During the 2-Dose Varicella Vaccination Program - United States, 2005-2014","volume":"65","author":"Lopez","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025090700454702000_105.1.24.25","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/129.2.215"}],"container-title":["Archives of disease in childhood - Education &amp; practice edition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2018-316715","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T07:45:55Z","timestamp":1757231155000},"score":1,"resource":{"primary":{"URL":"https:\/\/ep.bmj.com\/lookup\/doi\/10.1136\/archdischild-2018-316715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,23]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,30]]},"published-print":{"date-parts":[[2020,2]]}},"alternative-id":["10.1136\/archdischild-2018-316715"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2018-316715","relation":{},"ISSN":["1743-0585","1743-0593"],"issn-type":[{"value":"1743-0585","type":"print"},{"value":"1743-0593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,23]]}}}